Showing results (321-330 of 568) with videos related to

Sort By:
Pageof 57
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|October 31, 2003
Evidence for quantitative domain dominance for verbal and spatial working memory in frontal and parietal cortexHenrik Walter, Volker Bretschneider, Georg Grön, et al.
Pflugers Archiv : European Journal of Physiology|September 30, 1976
Quadrupole mass filtering for registration of blood gas partial pressuresK W Beste, H Duchanova, G Hellige, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2008
Middle East coastal ecosystem response to middle-to-late Holocene abrupt climate changesD Kaniewski, E Paulissen, E Van Campo, et al.
International Journal of Implant Dentistry|October 18, 2016
Altered nasal airflow: an unusual complication following implant surgery in the anterior maxillaJan Wolff, K Hakki Karagozoglu, Jochen H Bretschneider, et al.
Genome Biology and Evolution|September 6, 2015
Conserved Cis-Regulatory Modules Control Robustness in Msx1 Expression at Single-Cell ResolutionKeith W Vance, Dan J Woodcock, John E Reid, et al.
Biophysical Journal|September 7, 2004
Mobile actin clusters and traveling waves in cells recovering from actin depolymerizationGünther Gerisch, Till Bretschneider, Annette Müller-Taubenberger, et al.
Heart (British Cardiac Society)|October 5, 2010
Impact of restrictive physiology on intrinsic diastolic right ventricular function and lusitropy in children and adolescents after repair of tetralogy of FallotChristian Apitz, Heiner Latus, Wolfhard Binder, et al.
Circulation|March 11, 1998
Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A2 and involves upregulation of thromboxane receptor mRNAT P Zucker, D Bönisch, S Muck, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Thromboxane A2 potentiates thrombin-induced proliferation of coronary artery smooth muscle cellsT P Zucker, D Bönisch, S Muck, et al.
British Journal of Pharmacology|December 3, 2017
Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosisManuel Baader, Tom Bretschneider, Andre Broermann, et al.
Pageof 57